Breaking News Instant updates and real-time market news.

WNS

WNS Holdings

$63.78 /

+3.16 (+5.21%)

07:43
10/18/19
10/18
07:43
10/18/19
07:43

WNS Holdings price target raised to $73 from $68 at Cantor Fitzgerald

Cantor Fitzgerald analyst Joseph Foresi raised his price target for WNS Holdings to $73 from $68 following the company's "solid" Q2 results. The analyst sees room for multiple expansion as the company continues to outperform expectations and maintains an Overweight rating on the name.

  • 22

    Oct

  • 11

    Nov

  • 18

    Nov

  • 19

    Nov

WNS WNS Holdings
$63.78 /

+3.16 (+5.21%)

10/18/19 Citi
WNS Holdings price target raised to $74 from $69 at Citi
09/13/19 Berenberg
WNS Holdings initiated with a Buy at Berenberg
07/19/19 Barrington
WNS Holdings price target raised to $72 from $68 at Barrington
07/19/19 Cowen
WNS Holdings price target raised to $70 from $62 at Cowen

TODAY'S FREE FLY STORIES

Conference/Events
FDA PDUFA Date for Bempedoic Acid/Ezetimibe Combination Tablet February 26, 2020  09:00
02/26/20
02/26
09:00
02/26/20
09:00
ESPR

Esperion

$59.97 /

-2.84 (-4.52%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
U.S. equities are firmer » 09:00
02/26/20
02/26
09:00
02/26/20
09:00

U.S. equities are firmer,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Sunrun management to meet with JMP Securities » 08:59
02/26/20
02/26
08:59
02/26/20
08:59
RUN

Sunrun

$20.83 /

-1.29 (-5.83%)

Meeting to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Palihapitiya a 'net seller' of mega-cap tech 'FANG' stocks aside from Amazon » 08:59
02/26/20
02/26
08:59
02/26/20
08:59
AMZN

Amazon.com

$1,972.96 /

-36.78 (-1.83%)

, FB

Facebook

$196.75 /

-4.02 (-2.00%)

, NFLX

Netflix

$360.29 /

-8.25 (-2.24%)

, GOOGL

Alphabet Class A

$1,386.48 /

-33.97 (-2.39%)

, GOOG

Alphabet

$1,389.50 /

-33.39 (-2.35%)

Social Capital CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Cooper-Standard price target lowered to $25 from $47 at Roth Capital » 08:59
02/26/20
02/26
08:59
02/26/20
08:59
CPS

Cooper-Standard

$17.96 /

-1.895 (-9.54%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
TopBuild price target raised to $115 from $100 at SunTrust » 08:58
02/26/20
02/26
08:58
02/26/20
08:58
BLD

TopBuild

$113.86 /

-7.44 (-6.13%)

SunTrust analyst Keith…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Perficient price target raised to $52 from $46 at Barrington » 08:57
02/26/20
02/26
08:57
02/26/20
08:57
PRFT

Perficient

$44.12 /

-5.23 (-10.60%)

Barrington analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Syndicate
Karyopharm files automatic mixed securities shelf  08:56
02/26/20
02/26
08:56
02/26/20
08:56
KPTI

Karyopharm

$14.50 /

-0.31 (-2.09%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Lamar Advertising price target raised to $92 from $82 at MKM Partners » 08:55
02/26/20
02/26
08:55
02/26/20
08:55
LAMR

Lamar Advertising

$88.65 /

-2.84 (-3.10%)

MKM Partners analyst Eric…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Notable open interest changes for February 26th » 08:55
02/26/20
02/26
08:55
02/26/20
08:55
MSFT

Microsoft

$168.06 /

-2.82 (-1.65%)

, BAC

Bank of America

$31.10 /

-1.63 (-4.98%)

, AAPL

Apple

$288.08 /

-10.08 (-3.38%)

, TSLA

Tesla

$799.75 /

-34.07 (-4.09%)

Tuesday's total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Penumbra weakness buying opportunity, says Canaccord » 08:54
02/26/20
02/26
08:54
02/26/20
08:54
PEN

Penumbra

$176.15 /

-8.13 (-4.41%)

Canaccord analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Fate Therapeutics price target raised to $40 from $33 at Mizuho » 08:54
02/26/20
02/26
08:54
02/26/20
08:54
FATE

Fate Therapeutics

$30.35 /

-0.37 (-1.20%)

Mizuho analyst Mara…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Regeneron upgraded to Outperform from Market Perform at Bernstein » 08:53
02/26/20
02/26
08:53
02/26/20
08:53
REGN

Regeneron

$442.34 /

+16.05 (+3.77%)

, NVS

Novartis

$88.01 /

-2.06 (-2.29%)

Bernstein analyst Aaron…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Telus announces closing of C$1.5B equity offering » 08:53
02/26/20
02/26
08:53
02/26/20
08:53
TU

Telus

$38.22 /

-0.51 (-1.32%)

TELUS Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Federal Reserve Bank of Chicago and Euro Central Bank to co-host forum » 08:53
02/26/20
02/26
08:53
02/26/20
08:53

International Research…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Current partners with Cardtronics to offer surcharge-free access » 08:52
02/26/20
02/26
08:52
02/26/20
08:52
CATM

Cardtronics

$38.30 /

+0.07 (+0.18%)

Current is partnering…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Opera shares 'too cheap to ignore,' says Lake Street » 08:52
02/26/20
02/26
08:52
02/26/20
08:52
OPRA

Opera

$7.18 /

+0.045 (+0.63%)

Opera reported another…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Nomura to hold a forum » 08:52
02/26/20
02/26
08:52
02/26/20
08:52

Global Real Estate Forum…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
RE/MAX Holdings management to meet with JMP Securities » 08:51
02/26/20
02/26
08:51
02/26/20
08:51
RMAX

RE/MAX Holdings

$31.31 /

-1.29 (-3.96%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Oneok upgraded to Buy from Hold at Stifel » 08:51
02/26/20
02/26
08:51
02/26/20
08:51
OKE

Oneok

$73.66 /

-1.41 (-1.88%)

Stifel analyst Selman…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Performant Financial sees 2020 revenue $170M-$180M, one est. $175.4M » 08:50
02/26/20
02/26
08:50
02/26/20
08:50
PFMT

Performant Financial

$1.15 /

+ (+0.00%)

Sees adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Upgrade
Regeneron competitive concerns decrease, Canaccord upgrades to Buy » 08:50
02/26/20
02/26
08:50
02/26/20
08:50
REGN

Regeneron

$442.34 /

+16.05 (+3.77%)

, NVS

Novartis

$88.01 /

-2.06 (-2.29%)

As reported previously,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
PGT Innovations price target raised to $20 from $18 at B. Riley FBR » 08:49
02/26/20
02/26
08:49
02/26/20
08:49
PGTI

PGT Innovations

$17.13 /

-0.045 (-0.26%)

B. Riley FBR analyst Alex…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Performant Financial sees Q4 revenue $43M-$44M, one est. $40.8M » 08:49
02/26/20
02/26
08:49
02/26/20
08:49
PFMT

Performant Financial

$1.15 /

+ (+0.00%)

Sees adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Red Robin price target lowered to $30 from $35 at Wells Fargo » 08:48
02/26/20
02/26
08:48
02/26/20
08:48
RRGB

Red Robin

$31.32 /

-3.84 (-10.92%)

Wells Fargo analyst Jon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.